DAPASUG-M - Dapagliflozin 10mg + Metformin 500mg ER | Intralife Pharmaceuticals
DIASAGE
FeaturedTop

DAPASUG-M

MRP: 1,781

Packaging: 10x15

Pack Type: tablet

Composition:

Dapagliflozin 10mg + Metformin 500mg ER

Indication:

Patients with heart failure with reduced ejection fraction, to reduce the risk of CV death and hospitalization for heart failure, Patients with T2D with eCVD or multiple CV risk factors, to reduce the risk of hospitalization for heart failure

Description:

Dapagliflozin 10 mg + Metformin 500 mg ER is a fixed-dose combination oral medication used in the management of Type 2 Diabetes Mellitus. It combines two antidiabetic agents with complementary mechanisms:

  • Dapagliflozin is an SGLT2 inhibitor that lowers blood glucose by promoting its excretion in urine via the kidneys.

  • Metformin (Extended Release) improves insulin sensitivity and reduces hepatic glucose production, offering sustained blood sugar control over time.

This combination not only aids in achieving target glycemic levels but also provides additional benefits like weight reduction, blood pressure control, and cardio-renal protection. It is often prescribed when monotherapy is insufficient for optimal blood sugar control.

Tags:

Type 2 Diabetes Combination Therapy SGLT2 Inhibitor Oral Antidiabetic Extended Release
  • Dual mechanism offers improved glycemic control
  • Helps reduce HbA1c levels effectively
  • Aids in weight management
  • May lower blood pressure
  • Reduces risk of cardiovascular and kidney complications in diabetics

Usage Information

Dosage

Recommended Dose: One tablet daily or as prescribed Should be taken with meals to reduce GI upset Swallow whole; do not crush or chew Take consistently at the same time each day Do not skip or double dose without consulting your doctor

Side Effects

Genital infections or urinary tract infections Nausea, diarrhea, or abdominal discomfort Dehydration or low blood pressure Rare: Lactic acidosis (due to Metformin), ketoacidosis (due to Dapagliflozin) Headache or metallic taste

Contraindications

Known hypersensitivity to Dapagliflozin or Metformin Type 1 Diabetes or diabetic ketoacidosis Severe renal impairment or acute kidney injury History of lactic acidosis Unstable heart failure or recent myocardial infarction Alcohol abuse or liver dysfunction

Availability

Dapagliflozin Metformin ER tablets Type 2 Diabetes combination therapy Dapagliflozin 10mg Metformin 500mg Blood sugar control tablets SGLT2 inhibitor with metformin Extended-release diabetes medicine Weight loss diabetes medicine Diabetes tablets for adults Oral hypoglycemic combination Metformin sustained release with Dapagliflozin

Dapagliflozin 10 mg + Metformin ER 500 mg | Intralife Pharmaceuticals | Intralife